147 related articles for article (PubMed ID: 2461406)
1. Antiallergic activity of H1-receptor antagonists assessed by nasal challenge.
Bousquet J; Lebel B; Chanal I; Morel A; Michel FB
J Allergy Clin Immunol; 1988 Nov; 82(5 Pt 1):881-7. PubMed ID: 2461406
[TBL] [Abstract][Full Text] [Related]
2. Suppressive effect of loratadine on allergen-induced histamine release in the nose.
Andersson M; Nolte H; Baumgarten C; Pipkorn U
Allergy; 1991 Oct; 46(7):540-6. PubMed ID: 1724592
[TBL] [Abstract][Full Text] [Related]
3. Loratadine (SCH29851) 40 mg once daily versus terfenadine 60 mg twice daily in the treatment of seasonal allergic rhinitis.
Bruttmann G; Pedrali P
J Int Med Res; 1987; 15(2):63-70. PubMed ID: 2884152
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis.
Del Carpio J; Kabbash L; Turenne Y; Prevost M; Hebert J; Bedard PM; Nedilski M; Gutkowski A; Schulz J
J Allergy Clin Immunol; 1989 Nov; 84(5 Pt 1):741-6. PubMed ID: 2572617
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitis.
Gutkowski A; Bedard P; Del Carpio J; Hebert J; Prevost M; Schulz J; Turenne Y; Yeadon C
J Allergy Clin Immunol; 1988 May; 81(5 Pt 1):902-7. PubMed ID: 2897388
[TBL] [Abstract][Full Text] [Related]
6. A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis.
Horak F; Bruttmann G; Pedrali P; Weeke B; Frølund L; Wolff HH; Christophers E
Arzneimittelforschung; 1988 Jan; 38(1):124-8. PubMed ID: 2896508
[TBL] [Abstract][Full Text] [Related]
7. Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine.
Persi L; Demoly P; Harris AG; Tisserand B; Michel FB; Bousquet J
J Allergy Clin Immunol; 1999 Apr; 103(4):591-4. PubMed ID: 10200006
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of once daily loratadine versus terfenadine in the treatment of allergic rhinitis.
Banov CH
J Int Med Res; 1989; 17(2):150-6. PubMed ID: 2566536
[TBL] [Abstract][Full Text] [Related]
9. Effects of loratadine and terfenadine on the induced nasal allergic reaction.
Baroody FM; Lim MC; Proud D; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
Arch Otolaryngol Head Neck Surg; 1996 Mar; 122(3):309-16. PubMed ID: 8607960
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of an oral antihistamine, loratadine, as compared with a nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis.
Frølund L
Clin Otolaryngol Allied Sci; 1991 Dec; 16(6):527-31. PubMed ID: 1685945
[TBL] [Abstract][Full Text] [Related]
11. Suppression of epicutaneous reactivity by terfenadine and loratadine.
Small P
Ann Allergy; 1992 Jan; 68(1):30-4. PubMed ID: 1346563
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of single doses of the new H1-receptor antagonists loratadine and terfenadine versus placebo in children.
Simons FE; Lukowski JL; Becker AB; Simons KJ
J Pediatr; 1991 Feb; 118(2):298-300. PubMed ID: 1671591
[No Abstract] [Full Text] [Related]
13. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
Naclerio RM; Kagey-Sobotka A; Lichtenstein LM; Freidhoff L; Proud D
Am Rev Respir Dis; 1990 Jul; 142(1):167-71. PubMed ID: 1695070
[TBL] [Abstract][Full Text] [Related]
14. Changes in skin-test reactivity do not correlate with clinical efficacy of H1-blockers in seasonal allergic rhinitis.
Bousquet J; Czarlewski W; Cougnard J; Danzig M; Michel FB
Allergy; 1998 Jun; 53(6):579-85. PubMed ID: 9689339
[TBL] [Abstract][Full Text] [Related]
15. H1-receptor antagonist treatment of seasonal allergic rhinitis.
Kaiser HB
J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 2):1000-3. PubMed ID: 1979793
[TBL] [Abstract][Full Text] [Related]
16. Effects of fexofenadine on the early response to nasal allergen challenge.
Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
[TBL] [Abstract][Full Text] [Related]
17. Effect of terfenadine and placebo on symptoms after nasal allergen provocation.
Rökenes HK; Andersson B; Rundcrantz H
Clin Allergy; 1988 Jan; 18(1):63-9. PubMed ID: 2894904
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis.
Boner AL; Miglioranzi P; Richelli C; Marchesi E; Andreoli A
Allergy; 1989 Aug; 44(6):437-41. PubMed ID: 2572182
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and safety of loratadine in perennial allergic rhinitis.
Bruttmann G; Charpin D; Germouty J; Horak F; Kunkel G; Wittmann G
J Allergy Clin Immunol; 1989 Feb; 83(2 Pt 1):411-6. PubMed ID: 2563743
[TBL] [Abstract][Full Text] [Related]
20. Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains.
Lebel B; Bousquet J; Morel A; Chanal I; Godard P; Michel FB
J Allergy Clin Immunol; 1988 Nov; 82(5 Pt 1):869-77. PubMed ID: 2461405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
